Objectives: The aim of this study was to determine the relationship between atheroma
regression and arterial wall remodeling. Background: Infusion of reconstituted high-density …

Objectives: This study sought to assess the effect of short-term apolipoprotein (apo) A-
IMilano administration on plaque size and on suspected markers of plaque vulnerability …

ContextHigh-density lipoprotein (HDL) cholesterol is an inverse predictor of coronary
atherosclerotic disease. Preliminary data have suggested that HDL infusions can induce …

OBJECTIVES We sought to evaluate the plaque and patient variables related to arterial
remodeling responses of early, de novo atherosclerotic lesions involving the left coronary …

BACKGROUND Several epidemiological studies have shown an inverse relation between
high-density lipoprotein (HDL) cholesterol levels and coronary heart disease. Recently …

Objectives: This study sought to evaluate in vivo the minimal dose of apolipoprotein (apo) A-
IMilano phospholipid complex (recombinant apoA-IMilano and 1-palmitoyl-2-oleoyl …

Importance Infusing a high-density lipoprotein mimetic containing apolipoprotein AI Milano
demonstrated potential atheroma regression in patients following an acute coronary …

Objectives. This study sought to examine whether lipoprotein (a) levels predict coronary
artery lumen changes in patients with symptomatic coronary artery disease (CAD) and …

Relative changes in lumen size during progression and regression of coronary
atherosclerosis remain largely unknown. We assessed these changes using serial …

Aims On the basis of the evidence from autopsy studies, it is accepted that compensatory
enlargement (remodelling) of coronary arteries during progression of atherosclerosis …